Trial Profile
A dose-finding phase II study of TAS-108
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs SR 16234 (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 02 Oct 2012 New source identified and integrated.
- 01 Sep 2012 Results published in Cancer Science.
- 05 Nov 2010 New trial record.